Nivolumab-Induced Bullous Pemphigoid Managed without Drug Withdrawal

The widespread use of anti-programmed cell death receptor-1 (PD-1) agents has shed light to unusual immune-related adverse effects, especially affecting the skin. We report a case of bullous pemphigoid secondary to nivolumab therapy for metastatic renal carcinoma with a previously unreported complet...

Descripción completa

Detalles Bibliográficos
Autores principales: Munera-Campos, Mónica, Plana-Pla, Adrià, Rivera, Noelia, Boada, Aram, Ferrándiz, Carlos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292470/
https://www.ncbi.nlm.nih.gov/pubmed/32565564
http://dx.doi.org/10.4103/ijd.IJD_321_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292470/
https://www.ncbi.nlm.nih.gov/pubmed/32565564
http://dx.doi.org/10.4103/ijd.IJD_321_18

Ejemplares similares